NIMRAD - A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer

CLINICAL ONCOLOGY

ELSEVIER SCIENCE LONDON

1. MRC [G0801525] Funding Source: UKRI
2. Cancer Research UK [15729, 17977] Funding Source: researchfish
3. Medical Research Council [G0801525] Funding Source: researchfish
4. Cancer Research UK Funding Source: Medline
5. Medical Research Council [G0801525] Funding Source: Medline